Stay updated on Nivolumab Plus SBRT in Metastatic RCC Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Plus SBRT in Metastatic RCC Clinical Trial page.

Latest updates to the Nivolumab Plus SBRT in Metastatic RCC Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe page’s footer release revision/version was updated from **v3.5.2** to **v3.5.3** without any apparent change to the underlying study information.SummaryDifference0.1%

- Check24 days agoChange DetectedPage revision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check53 days agoChange DetectedRevision label updated from v3.4.3 to v3.5.0 in the page footer.SummaryDifference0.1%

- Check68 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. This appears to be a backend version update with no user-facing changes.SummaryDifference0.1%

- Check89 days agoChange DetectedMinor version update noted: v3.4.2 has been added and v3.4.1 removed. This appears to be a maintenance change rather than a change to study data or user actions.SummaryDifference0.1%

- Check97 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1; no visible changes to study details or page layout are observed.SummaryDifference0.1%

Stay in the know with updates to Nivolumab Plus SBRT in Metastatic RCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus SBRT in Metastatic RCC Clinical Trial page.